BRIEF-Sichuan Biokin's Unit Receives $250 Mln Milestone Payment From BMS On Iza-Bren Agreement

Reuters11-30

BRIEF-<a href="https://laohu8.com/S/688506">Sichuan Biokin</a>'s Unit Receives $250 Mln Milestone Payment From BMS On Iza-Bren Agreement

Nov 30 (Reuters) - Sichuan Biokin Pharmaceutical Co Ltd 688506.SS:

SAYS UNIT HAS RECEIVED $250 MILLION MILESTONE PAYMENT FROM BRISTOL-MYERS SQUIBB $(BMS)$ RECENTLY IN ACCORDANCE TO IZA-BREN GLOBAL STRATEGIC AGREEMENT
SAYS CO REMAINS ELIGIBLE FOR UP TO $250 MILLION NEAR-TERM PAYMENTS, UP TO $7.1 BILLION ADDITIONAL PAYMENTS UPON ACHIEVING SPECIFIC DEVELOPMENT, REGULATORY, COMMERCIAL MILESTONES

Source text

Further company coverage: 688506.SS

(Reporting by Hong Kong newsroom)

((donny.kwok@thomsonreuters.com; +852 3462 7745;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2587446799?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-30 17:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2587446799","market":"fut","top_or_hot":-1,"title":"BRIEF-Sichuan Biokin's Unit Receives $250 Mln Milestone Payment From BMS On Iza-Bren Agreement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/688506\">Sichuan Biokin</a>'s Unit Receives $250 Mln Milestone Payment From BMS On Iza-Bren Agreement</title></head><body><p><span>Nov 30 (Reuters)</span><span> - </span>Sichuan Biokin Pharmaceutical Co Ltd <span>688506.SS</span>:</p><ul><li><p>SAYS UNIT HAS RECEIVED $250 MILLION MILESTONE PAYMENT FROM BRISTOL-MYERS SQUIBB <a href=\"https://laohu8.com/S/BMS\">$(BMS)$</a> RECENTLY IN ACCORDANCE TO IZA-BREN GLOBAL STRATEGIC AGREEMENT</p></li><li><p>SAYS CO REMAINS ELIGIBLE FOR UP TO $250 MILLION NEAR-TERM PAYMENTS, UP TO $7.1 BILLION ADDITIONAL PAYMENTS UPON ACHIEVING SPECIFIC DEVELOPMENT, REGULATORY, COMMERCIAL MILESTONES</p></li></ul><p>Source text</p><p>Further company coverage: <span>688506.SS</span></p><p> (Reporting by Hong Kong newsroom)</p><p> ((donny.kwok@thomsonreuters.com; +852 3462 7745;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Sichuan Biokin's Unit Receives $250 Mln Milestone Payment From BMS On Iza-Bren Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Sichuan Biokin's Unit Receives $250 Mln Milestone Payment From BMS On Iza-Bren Agreement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-30 17:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/688506\">Sichuan Biokin</a>'s Unit Receives $250 Mln Milestone Payment From BMS On Iza-Bren Agreement</title></head><body><p><span>Nov 30 (Reuters)</span><span> - </span>Sichuan Biokin Pharmaceutical Co Ltd <span>688506.SS</span>:</p><ul><li><p>SAYS UNIT HAS RECEIVED $250 MILLION MILESTONE PAYMENT FROM BRISTOL-MYERS SQUIBB <a href=\"https://laohu8.com/S/BMS\">$(BMS)$</a> RECENTLY IN ACCORDANCE TO IZA-BREN GLOBAL STRATEGIC AGREEMENT</p></li><li><p>SAYS CO REMAINS ELIGIBLE FOR UP TO $250 MILLION NEAR-TERM PAYMENTS, UP TO $7.1 BILLION ADDITIONAL PAYMENTS UPON ACHIEVING SPECIFIC DEVELOPMENT, REGULATORY, COMMERCIAL MILESTONES</p></li></ul><p>Source text</p><p>Further company coverage: <span>688506.SS</span></p><p> (Reporting by Hong Kong newsroom)</p><p> ((donny.kwok@thomsonreuters.com; +852 3462 7745;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE0009355771.USD","symbol_name":"骏利亨德森环球生命科技A Acc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251130:nL4N3X602O:1","article_id":"2587446799","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2587446799","pubTimestamp":1764494203,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Sichuan Biokin's Unit Receives $250 Mln Milestone Payment From BMS On Iza-Bren AgreementNov 30  - Sichuan Biokin Pharmaceutical Co Ltd 688506.SS:SAYS UNIT HAS RECEIVED $250 MILLION MILESTONE PAYMENT FROM BRISTOL-MYERS SQUIBB  RECENTLY IN ACCORDANCE TO IZA-BREN GLOBAL STRATEGIC AGREEMENTSAYS CO REMAINS ELIGIBLE FOR UP TO $250 MILLION NEAR-TERM PAYMENTS, UP TO $7.1 BILLION ADDITIONAL PAYMENTS UPON ACHIEVING SPECIFIC DEVELOPMENT, REGULATORY, COMMERCIAL MILESTONESSource textFurther company coverage: 688506.SS  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688506":"百利天恒","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","BK4588":"碎股","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","LU1670710588.SGD":"M&G (LUX) GLOBAL DIVIDEND \"A\" (SGD) ACC","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU0237698245.USD":"富达环球地产基金A","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1868836914.USD":"CT (LUX) I AMERICAN \"3\" (USD) ACC","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","BK4532":"文艺复兴科技持仓","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","LU1670711123.USD":"M&G (LUX) GLOBAL DIVIDEND \"A\" (USD) INC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU1323610961.USD":"UBS (LUX) EQUITY SICAV - LONG TERM THEMES (USD) \"P\" (USD) ACC","LU0225771236.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (USD) INC MF","LU1868836591.USD":"CT (LUX) I AMERICAN \"1U\"(USD) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU2360032135.SGD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (SGDHDG) INC","BMY":"施贵宝","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU2125154778.USD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (USD) INC","LU1032466523.USD":"高盛全球多资产收益组合Acc","LU0882574055.USD":"富达全球健康医疗A ACC","BK0239":"医药制造","LU1670711040.USD":"M&G (LUX) GLOBAL DIVIDEND \"A\" (USD) ACC","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","LU1261432733.SGD":"Fidelity World A-ACC-SGD","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU0306807586.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" (USD) INC QF","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU0985481810.HKD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (HKD) INC M","LU0225284248.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" ACC","BK4559":"巴菲特持仓","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","LU1074936037.SGD":"JPMorgan Funds - US Value A (acc) SGD","LU2242646821.SGD":"Fidelity Global Dividend Plus A-MINCOME(G)-SGD"},"translate_title":"简报-四川Biokin的子公司根据Iza-Bren协议从BMS获得2.5亿美元的里程碑付款","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688506":0.9,"BMY":0.9},"content_text":"BRIEF-Sichuan Biokin's Unit Receives $250 Mln Milestone Payment From BMS On Iza-Bren AgreementNov 30 (Reuters) - Sichuan Biokin Pharmaceutical Co Ltd 688506.SS:SAYS UNIT HAS RECEIVED $250 MILLION MILESTONE PAYMENT FROM BRISTOL-MYERS SQUIBB $(BMS)$ RECENTLY IN ACCORDANCE TO IZA-BREN GLOBAL STRATEGIC AGREEMENTSAYS CO REMAINS ELIGIBLE FOR UP TO $250 MILLION NEAR-TERM PAYMENTS, UP TO $7.1 BILLION ADDITIONAL PAYMENTS UPON ACHIEVING SPECIFIC DEVELOPMENT, REGULATORY, COMMERCIAL MILESTONESSource textFurther company coverage: 688506.SS (Reporting by Hong Kong newsroom) ((donny.kwok@thomsonreuters.com; +852 3462 7745;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2587446799","isCrawlerRequest":true}